Antigens of activated rat T lymphocytes including a molecule of 50,000 Mr detected only on CD4 positive T blasts
about
Herpesvirus entry mediator ligand (HVEM-L), a novel ligand for HVEM/TR2, stimulates proliferation of T cells and inhibits HT29 cell growthIdentification of a human OX-40 ligand, a costimulator of CD4+ T cells with homology to tumor necrosis factorMolecular characterization of murine and human OX40/OX40 ligand systems: identification of a human OX40 ligand as the HTLV-1-regulated protein gp34CD147 is tightly associated with lactate transporters MCT1 and MCT4 and facilitates their cell surface expressionIdentification of a novel surface protein on activated CD4+ T cells that induces contact-dependent B cell differentiation (help)Evidence that the T cell repertoire of normal rats contains cells with the potential to cause diabetes. Characterization of the CD4+ T cell subset that inhibits this autoimmune potentialOX-22high CD4+ T cells induce wasting disease with multiple organ pathology: prevention by the OX-22low subsetA novel form of the membrane protein CD147 that contains an extra Ig-like domain and interacts homophilicallyCD134 as target for specific drug delivery to auto-aggressive CD4+ T cells in adjuvant arthritisHow, with whom and when: an overview of CD147-mediated regulatory networks influencing matrix metalloproteinase activityStrategies for combining immunotherapy with radiation for anticancer therapyImmunotherapy in the treatment of non-small cell lung cancerScience gone translational: the OX40 agonist storyActivation of OX40 signal transduction pathways leads to tumor necrosis factor receptor-associated factor (TRAF) 2- and TRAF5-mediated NF-kappaB activationCharacterization of the MRC OX40 antigen of activated CD4 positive T lymphocytes--a molecule related to nerve growth factor receptorRANTES plays an important role in the evolution of allograft transplant-induced fibrous airway obliterationBlood lymphocyte subsets in rats with adjuvant arthritis.Arthritis in Lewis rats induced by the non-immunogenic adjuvant CP20961: an immunohistochemical analysis of the developing diseaseAntigen-specific CD4+ T cells drive airway smooth muscle remodeling in experimental asthma.Control of immunity by the TNFR-related molecule OX40 (CD134)Antibody-based immunotherapy for malignant glioma.OX40 is a potent immune-stimulating target in late-stage cancer patients.The significance of OX40 and OX40L to T-cell biology and immune disease.Simvastatin reduces OX40 and OX40 ligand expression in human peripheral blood mononuclear cells and in patients with atherosclerotic cerebral infarction.Expression of lymphocyte-endothelial receptor-ligand pairs, alpha4beta7/MAdCAM-1 and OX40/OX40 ligand in the colon and jejunum of patients with inflammatory bowel diseaseAgonist antibodies to TNFR molecules that costimulate T and NK cellsTNF superfamily protein-protein interactions: feasibility of small- molecule modulationT-cell costimulatory pathways in allograft rejection and tolerance.OX40/OX40 ligand interactions in T-cell regulation and asthmaImmunopathological features of rat Staphylococcus aureus arthritis.Therapeutic targeting of the effector T-cell co-stimulatory molecule OX40.Phenotypic analysis of pulmonary perivascular mononuclear infiltrates that occur as a direct result of acute lethal graft-versus-host disease describes the onset of interstitial pneumonitisDevelopment and characterization of recombinant human Fc:OX40L fusion protein linked via a coiled-coil trimerization domainCytolytic T cells recognize a chimeric MHC class I antigen expressed in influenza A infected transgenic mice.Probing the interaction between feline immunodeficiency virus and CD134 by using the novel monoclonal antibody 7D6 and the CD134 (Ox40) ligandT cell receptor-mediated selection of functional rat CD8 T cells from defined immature thymocyte precursors in short-term suspension culture.Major histocompatibility complex-expressing nonhematopoietic astroglial cells prime only CD8+ T lymphocytes: astroglial cells as perpetuators but not initiators of CD4+ T cell responses in the central nervous systemSpecific unresponsiveness in rats with prolonged cardiac allograft survival after treatment with cyclosporine. III. Further characterization of the CD4+ suppressor cell and its mechanisms of action.Anti-interleukin 2 receptor monoclonal antibodies spare phenotypically distinct T suppressor cells in vivo and exert synergistic biological effects.Co-stimulatory molecules as potential targets for therapeutic intervention in allergic airway disease.
P2860
Q22003914-DD138DE9-9E01-4D7E-BD05-50DEFF1E15D9Q24319938-A7C5C968-608B-45FB-822D-43412699304AQ24568305-64A797D1-C56B-4295-B7EE-75E9B37E80A8Q24630430-05B00F21-AB21-41A4-9E1B-BD153889C73DQ24675460-F5678D9B-F300-456D-B62D-2E8C6E458477Q24680634-FDF54C38-7A64-4AF4-B57F-C5DED536E41EQ24682576-81066EF7-E153-43A4-9E8D-B59781DD476AQ24796702-573C897F-DB6A-42D7-8539-DB22138DACF9Q24816831-30E52B2A-06D4-4F8E-BE66-63DBF63422D9Q26775999-05E688F9-BFC2-4AF5-9C55-48475EA0ACC3Q26796675-F89F65B4-CB0A-4B99-AE48-C7798F1F4592Q27000382-A9E37A10-6690-47A5-9388-B698427FD77DQ27022436-3295E532-BB87-4DF4-A5C7-2EFA94C87A23Q28263653-CE0A632C-954B-45F6-848E-AD1844F4BE16Q28576279-A9034536-B4E5-4F62-A4B4-15B1BF73EE0BQ28582072-3E562CB6-D486-40AB-A544-7AF6576C2810Q33566474-4003F9D7-C3EB-4CE6-A5D5-3A26B4998F4AQ33566695-F0157F18-F200-498E-AFD9-03755DC19966Q33771393-F33D429E-5055-4EA3-8DB5-E6EC84856232Q33899607-29A90851-7A57-43F5-AEC8-0CF39ECC10D7Q34120472-D5875C09-9B93-4781-B511-17625619E29FQ34381674-09FEDD54-F341-412E-B588-E197DF793951Q34979946-7C528A7C-A9C5-4279-8C8D-DB3009C21C32Q34991508-29CEF8F4-66D3-4A19-A5FC-92A548170606Q35357996-B67B63CB-86EF-4C76-9D49-8ACF4EAE67FEQ35427446-AF77F795-7F34-419B-AF75-0CFD3AD87C9FQ35534271-40AE3172-D3FC-46F4-A96D-29A734130ED9Q35583511-27DC461A-3816-4DD4-9A4B-9341745A96CBQ35750177-244E0F42-10E4-4120-9F11-30754C33548CQ35782083-DAA27AC3-072B-4379-AC46-0E5BB85B7EC1Q35790354-C929DB1C-2BAC-490E-A18A-A735B148BDB6Q35795515-65A5DD5D-97F1-4A6D-970D-DA35E62D27D8Q35946627-1AE794E7-F6FA-41D4-B81F-332190E4A505Q35993317-4ECC5B18-7314-4901-9DFB-6329802D2340Q36098854-0AD8ACFB-82D8-4A74-9693-FB09BE783D5AQ36230004-C1ADC1E5-490A-46BE-BA54-A4C7AF77177BQ36230080-3C441A99-5D96-4095-A9A8-75C49C1FA104Q36350238-512AA29B-E26E-45BA-962F-2129B1D43F33Q36357690-87D2D386-C43F-47E3-A5FC-AD504A83441BQ36360561-40A9BDEF-4810-4380-84AE-F473EC448FE7
P2860
Antigens of activated rat T lymphocytes including a molecule of 50,000 Mr detected only on CD4 positive T blasts
description
1987 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1987 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 1987
@ast
im Dezember 1987 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 1987/12/01)
@sk
vědecký článek publikovaný v roce 1987
@cs
wetenschappelijk artikel (gepubliceerd op 1987/12/01)
@nl
наукова стаття, опублікована в грудні 1987
@uk
مقالة علمية (نشرت في ديسمبر 1987)
@ar
name
Antigens of activated rat T ly ...... only on CD4 positive T blasts
@ast
Antigens of activated rat T ly ...... only on CD4 positive T blasts
@en
Antigens of activated rat T ly ...... only on CD4 positive T blasts
@nl
type
label
Antigens of activated rat T ly ...... only on CD4 positive T blasts
@ast
Antigens of activated rat T ly ...... only on CD4 positive T blasts
@en
Antigens of activated rat T ly ...... only on CD4 positive T blasts
@nl
prefLabel
Antigens of activated rat T ly ...... only on CD4 positive T blasts
@ast
Antigens of activated rat T ly ...... only on CD4 positive T blasts
@en
Antigens of activated rat T ly ...... only on CD4 positive T blasts
@nl
P2093
P4510
P1433
P1476
Antigens of activated rat T ly ...... only on CD4 positive T blasts
@en
P2093
A. F. Williams
D. J. Paterson
J. R. Green
M. Puklavec
M. R. Brandon
P. Corthesy
W. A. Jefferies
P304
P356
10.1016/0161-5890(87)90122-2
P577
1987-12-01T00:00:00Z